Nanomedicine and Nanoparticle Applications

Nanoparticles hold immense potential for improving human life, particularly in medicine, giving rise to the field of nanomedicine.
Nanomedicine involves using nanoparticles to develop new therapies and treatments.

A major area of interest involves pharmaceuticals that use nanotechnology to target specific tumors and encapsulate drugs.
This approach can potentially reduce the toxicity of treatments like chemotherapy.
Example: Abraxane
- Introduced in 2005 as an anticancer drug for breast cancer.
- Traditional drugs like Taxol are insoluble and require toxic chemicals for solubility.
- Abraxane's breakthrough: Making particles nanoscale (approximately 17 nanometers) and coating them in albumin.
- Albumin makes the particles soluble, significantly reducing toxicity.
- Abraxane represents a significant success in reducing treatment toxicity.

Black materials do not remain black when reduced to the nanoscale due to quantum effects.
Quantum dots: Nanoscale materials (semiconductors, etc.) that allow tuning of color based on particle size.
- Different colors arise from varying particle sizes, not different materials.
- Larger quantum dots appear black; as size decreases, they shift to red, then yellow, and so on, spanning the entire color spectrum.
- If non-toxic, quantum dots could replace potentially carcinogenic chemicals in cosmetic products.
- Companies like L'Oréal are investing in nanotechnology for skin products and pigment coloration.

Nanodots can be used to tag specific types of diseases.
Nanoparticles smaller than approximately 4 nanometers can cross the blood-brain barrier and enter cells.
This characteristic makes them attractive for targeted pharmaceuticals.
They can specifically target cells with internal receptors.
Through endocytosis, the particles are selectively absorbed into the cell.

Nanoshells are hollow nanoparticles.
When illuminated with near-infrared light, they heat up due to the behavior of electrons around the shell (plasmon effect).
Nanoshells are being tested in animals as a potential cancer therapy.
They can be targeted to specific cells using antigens or other molecules on their surface.
Illumination with near-infrared light causes them to heat up and selectively kill targeted tissue.

Nanoparticles offer transformative potential in medicine, leading to the development of nanomedicine.
Nanomedicine employs nanoparticles to create innovative therapies and treatments for various diseases and conditions.

Nanotechnology is used in pharmaceuticals to specifically target tumors and encapsulate drugs, enhancing treatment efficacy.
This targeted approach aims to decrease the toxicity associated with treatments like chemotherapy, improving patient outcomes.
Example: Abraxane
- Developed in 2005, Abraxane is an anticancer drug used in the treatment of breast cancer.
- Traditional drugs such as Taxol are insoluble and require toxic chemicals to enhance solubility, leading to adverse side effects.
- Abraxane's innovation: Particles are made nanoscale (approximately 17 nanometers) and coated in albumin, a protein found in blood.
- Albumin coating improves particle solubility, significantly reducing toxicity and improving drug delivery to the tumor site.
- Abraxane marks a substantial advancement in reducing treatment-related toxicity and enhancing therapeutic efficacy.

At the nanoscale, black materials exhibit altered properties due to quantum effects.
Quantum dots: These are nanoscale materials like semiconductors that exhibit tunable color properties based on particle size.
- Different particle sizes result in different colors, enabling a broad spectrum of colors from a single material.
- Larger quantum dots appear black; as size decreases, they shift to red, yellow, and other colors.
- Quantum dots have the potential to replace carcinogenic chemicals in cosmetics if proven non-toxic.
- Companies like L'Oréal are investing significantly in nanotechnology to develop advanced skin products and pigment coloration.

Nanodots can be engineered to selectively bind to specific disease markers, aiding in early diagnosis and targeted treatment.
Nanoparticles smaller than 4 nanometers can traverse the blood-brain barrier, enabling drug delivery to the brain.
This characteristic is valuable for developing targeted pharmaceuticals for neurological disorders.
Nanodots can target cells with internal receptors, enhancing drug uptake and therapeutic effects.
Through endocytosis, cells selectively absorb these particles, maximizing drug delivery to the intended site.

Nanoshells are hollow nanoparticles designed for targeted therapy and imaging applications.
When exposed to near-infrared light, nanoshells generate heat due to the collective oscillation of electrons (plasmon resonance).
Nanoshells are currently under investigation in animal studies as a potential cancer therapy, demonstrating promising results.
By attaching antigens or specific molecules to their surface, nanoshells can selectively target cancer cells.
Upon irradiation with near-infrared light, nanoshells heat up and destroy the targeted tissue, providing a localized cancer treatment.